Cargando…

LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort

OBJECTIVE: To determine if achieving lupus low disease activity state (LLDAS) or remission prevents damage accrual in a primarily Mestizo population. METHODS: Patients with SLE from a single-centre cohort with at least two visits occurring every 6 months were included. The definitions used were the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ugarte-Gil, Manuel Francisco, Gamboa-Cardenas, Rocio Violeta, Reátegui-Sokolova, Cristina, Pimentel-Quiroz, Victor Román, Medina, Mariela, Elera-Fitzcarrald, Claudia, Zevallos, Francisco, Pastor-Asurza, Cesar Augusto, Lofland, Jeniffer, Zazzetti, Federico, Karyekar, Chetan S, Alarcón, Graciela S, Perich-Campos, Risto Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867305/
https://www.ncbi.nlm.nih.gov/pubmed/35193948
http://dx.doi.org/10.1136/lupus-2021-000616
_version_ 1784656026701660160
author Ugarte-Gil, Manuel Francisco
Gamboa-Cardenas, Rocio Violeta
Reátegui-Sokolova, Cristina
Pimentel-Quiroz, Victor Román
Medina, Mariela
Elera-Fitzcarrald, Claudia
Zevallos, Francisco
Pastor-Asurza, Cesar Augusto
Lofland, Jeniffer
Zazzetti, Federico
Karyekar, Chetan S
Alarcón, Graciela S
Perich-Campos, Risto Alfredo
author_facet Ugarte-Gil, Manuel Francisco
Gamboa-Cardenas, Rocio Violeta
Reátegui-Sokolova, Cristina
Pimentel-Quiroz, Victor Román
Medina, Mariela
Elera-Fitzcarrald, Claudia
Zevallos, Francisco
Pastor-Asurza, Cesar Augusto
Lofland, Jeniffer
Zazzetti, Federico
Karyekar, Chetan S
Alarcón, Graciela S
Perich-Campos, Risto Alfredo
author_sort Ugarte-Gil, Manuel Francisco
collection PubMed
description OBJECTIVE: To determine if achieving lupus low disease activity state (LLDAS) or remission prevents damage accrual in a primarily Mestizo population. METHODS: Patients with SLE from a single-centre cohort with at least two visits occurring every 6 months were included. The definitions used were the following: for remission, the 2021 Definition Of Remission In SLE; and for LLDAS, the Asia Pacific Lupus Collaboration. Damage accrual was ascertained with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Univariable and three multivariable interval-censored survival regression models were done: (1) remission versus not on remission; (2) LLDAS/remission versus active; and (3) remission and LLDAS (not on remission) versus active. Three similar multivariable models were also examined considering the duration on each state. Possible confounders included in these analyses were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use and SDI at baseline. RESULTS: Two hundred and eighty-one patients were included. Eighty-three patients (29.5%) showed increased SDI during the follow-up. In the analyses of remission, being on remission predicted a lower probability of damage (HR=0.456; 95% CI 0.256 to 0.826; p=0.010). In the analyses of LLDAS/remission, being on LLDAS/remission predicted a lower damage (HR=0.503; 95% CI 0.260 to 0.975; p=0.042). When both states were considered, remission but not LLDAS (not on remission) predicted a lower probability of damage (HR=0.423; 95% CI 0.212 to 0.846; p=0.015 and HR=0.878; 95% CI 0.369 to 2.087; p=0.768, respectively). When the duration of these states was taken into account, remission, LLDAS/remission and LLDAS not on remission were associated with a lower probability of damage accrual. CONCLUSIONS: LLDAS and/or remission were associated with a lower probability of damage accrual.
format Online
Article
Text
id pubmed-8867305
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88673052022-03-15 LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort Ugarte-Gil, Manuel Francisco Gamboa-Cardenas, Rocio Violeta Reátegui-Sokolova, Cristina Pimentel-Quiroz, Victor Román Medina, Mariela Elera-Fitzcarrald, Claudia Zevallos, Francisco Pastor-Asurza, Cesar Augusto Lofland, Jeniffer Zazzetti, Federico Karyekar, Chetan S Alarcón, Graciela S Perich-Campos, Risto Alfredo Lupus Sci Med Brief Communication OBJECTIVE: To determine if achieving lupus low disease activity state (LLDAS) or remission prevents damage accrual in a primarily Mestizo population. METHODS: Patients with SLE from a single-centre cohort with at least two visits occurring every 6 months were included. The definitions used were the following: for remission, the 2021 Definition Of Remission In SLE; and for LLDAS, the Asia Pacific Lupus Collaboration. Damage accrual was ascertained with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Univariable and three multivariable interval-censored survival regression models were done: (1) remission versus not on remission; (2) LLDAS/remission versus active; and (3) remission and LLDAS (not on remission) versus active. Three similar multivariable models were also examined considering the duration on each state. Possible confounders included in these analyses were gender, age at diagnosis, socioeconomic status, educational level, disease duration, antimalarial use and SDI at baseline. RESULTS: Two hundred and eighty-one patients were included. Eighty-three patients (29.5%) showed increased SDI during the follow-up. In the analyses of remission, being on remission predicted a lower probability of damage (HR=0.456; 95% CI 0.256 to 0.826; p=0.010). In the analyses of LLDAS/remission, being on LLDAS/remission predicted a lower damage (HR=0.503; 95% CI 0.260 to 0.975; p=0.042). When both states were considered, remission but not LLDAS (not on remission) predicted a lower probability of damage (HR=0.423; 95% CI 0.212 to 0.846; p=0.015 and HR=0.878; 95% CI 0.369 to 2.087; p=0.768, respectively). When the duration of these states was taken into account, remission, LLDAS/remission and LLDAS not on remission were associated with a lower probability of damage accrual. CONCLUSIONS: LLDAS and/or remission were associated with a lower probability of damage accrual. BMJ Publishing Group 2022-02-22 /pmc/articles/PMC8867305/ /pubmed/35193948 http://dx.doi.org/10.1136/lupus-2021-000616 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Brief Communication
Ugarte-Gil, Manuel Francisco
Gamboa-Cardenas, Rocio Violeta
Reátegui-Sokolova, Cristina
Pimentel-Quiroz, Victor Román
Medina, Mariela
Elera-Fitzcarrald, Claudia
Zevallos, Francisco
Pastor-Asurza, Cesar Augusto
Lofland, Jeniffer
Zazzetti, Federico
Karyekar, Chetan S
Alarcón, Graciela S
Perich-Campos, Risto Alfredo
LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title_full LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title_fullStr LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title_full_unstemmed LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title_short LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort
title_sort lldas (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily mestizo population: data from the almenara lupus cohort
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867305/
https://www.ncbi.nlm.nih.gov/pubmed/35193948
http://dx.doi.org/10.1136/lupus-2021-000616
work_keys_str_mv AT ugartegilmanuelfrancisco lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT gamboacardenasrociovioleta lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT reateguisokolovacristina lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT pimentelquirozvictorroman lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT medinamariela lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT elerafitzcarraldclaudia lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT zevallosfrancisco lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT pastorasurzacesaraugusto lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT loflandjeniffer lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT zazzettifederico lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT karyekarchetans lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT alarcongracielas lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort
AT perichcamposristoalfredo lldaslupuslowdiseaseactivitystateandorremissionareassociatedwithlessdamageaccrualinpatientswithsystemiclupuserythematosusfromaprimarilymestizopopulationdatafromthealmenaralupuscohort